French drugmaker Cellectis in sale talks -FT
May 28, 2015 at 17:03 PM EDT
May 28 (Reuters) - French cancer drugmaker Cellectis is in potential sale talks with a few suitors, including U.S. based Pfizer Inc, the Financial Times reported citing people familiar with the matter.
